Frazier Management as of Dec. 31, 2018
Portfolio Holdings for Frazier Management
Frazier Management holds 17 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 38.1 | $148M | 2.3M | 63.79 | |
| Aptinyx | 13.6 | $53M | 3.2M | 16.54 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 8.4 | $32M | 1.9M | 17.17 | |
| Gritstone Oncology Ord (GRTS) | 8.2 | $32M | 2.1M | 15.45 | |
| Iovance Biotherapeutics (IOVA) | 5.0 | $19M | 2.2M | 8.85 | |
| Krystal Biotech (KRYS) | 4.7 | $18M | 875k | 20.78 | |
| Allena Pharmaceuticals | 4.7 | $18M | 3.3M | 5.45 | |
| Millendo Therapeutics | 2.9 | $11M | 1.4M | 7.95 | |
| Sierra Oncology | 2.8 | $11M | 8.1M | 1.32 | |
| Alpine Immune Sciences (ALPN) | 2.1 | $8.1M | 2.2M | 3.68 | |
| Iterum Therapeutics | 2.0 | $7.7M | 1.5M | 5.01 | |
| Synlogic | 1.6 | $6.1M | 865k | 7.01 | |
| Kezar Life Sciences (KZR) | 1.5 | $5.9M | 250k | 23.60 | |
| Nabriva Therapeutics | 1.5 | $5.9M | 4.0M | 1.46 | |
| Entasis Therapeutics Holdings Ord | 1.4 | $5.5M | 1.3M | 4.07 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.8 | $3.1M | 1.3M | 2.35 | |
| Bellicum Pharma | 0.8 | $3.1M | 1.1M | 2.92 |
